Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioharvest Sciences (BHST) EBITDA (2023 - 2025)

Historic EBITDA for Bioharvest Sciences (BHST) over the last 3 years, with Q3 2025 value amounting to -$920000.0.

  • Bioharvest Sciences' EBITDA rose 5623.22% to -$920000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.1 million, marking a year-over-year increase of 7292.92%. This contributed to the annual value of -$7.0 million for FY2024, which is 2987.16% up from last year.
  • According to the latest figures from Q3 2025, Bioharvest Sciences' EBITDA is -$920000.0, which was up 5623.22% from -$1.8 million recorded in Q2 2025.
  • In the past 5 years, Bioharvest Sciences' EBITDA registered a high of $2.9 million during Q2 2023, and its lowest value of -$17.4 million during Q4 2023.
  • For the 3-year period, Bioharvest Sciences' EBITDA averaged around -$2.4 million, with its median value being -$1.7 million (2024).
  • Examining YoY changes over the last 5 years, Bioharvest Sciences' EBITDA showed a top increase of 9029.51% in 2024 and a maximum decrease of 20473.34% in 2024.
  • Quarter analysis of 3 years shows Bioharvest Sciences' EBITDA stood at -$17.4 million in 2023, then surged by 90.3% to -$1.7 million in 2024, then soared by 45.47% to -$920000.0 in 2025.
  • Its EBITDA was -$920000.0 in Q3 2025, compared to -$1.8 million in Q2 2025 and -$1.7 million in Q1 2025.